Answers are grounded in this paper and cite their sources.
Fatal agranulocytosis developed during treatment of a patient with dermatitis herpetiformis. Although he received other medications, dapsone was considered the probable cause of the agranulocytosis. Recent reports have documented the occurrence of dapsone-induced agranulocytosis during malaria prophylaxis. The present case emphasizes the possibility of this serious and sometimes fatal complication arising during sulfone therapy of dermatologicdisorders.
No takes yet. Share an insight, caveat, or question.
Broeke et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: